Preparation method of oral TGEV (transmissible gastroenteritis virus) deactivating microcapsule

A gastroenteritis and infectious technology, which is applied in the field of inactivation of porcine infectious gastroenteritis virus to achieve the effects of stable storage and transportation, cost saving and convenient use

Pending Publication Date: 2018-05-29
姜新鹏
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there is still little research on the prevention and control and application of animal diseases, especially in the prevention and control of pig diseases, only microcapsules are used to encapsulate the TGEV neutralizing antigen COE protein expressed by E. coli prokaryotic
Does not use microencapsulated preparations to encapsulate inactivated microorganisms, including porcine inactivated pathogenic bacteria and viruses

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of oral TGEV (transmissible gastroenteritis virus) deactivating microcapsule
  • Preparation method of oral TGEV (transmissible gastroenteritis virus) deactivating microcapsule
  • Preparation method of oral TGEV (transmissible gastroenteritis virus) deactivating microcapsule

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0025] Specific embodiment one: the microcapsule preparation method of oral inactivation porcine transmissible gastroenteritis virus of the present embodiment, it is to carry out according to the following steps: one, will infect porcine transmissible gastroenteritis virus strain subculture, in After subculture, 70-80% of the cells showed cytopathic effects. Collect the cultured virus strains, and place them in a -80°C ultra-low temperature refrigerator and room temperature for three times to freeze and thaw repeatedly to fully lyse the cells, and then 2000-4000r / min Centrifuge for 30 minutes, absorb the supernatant, which is the porcine transmissible gastroenteritis virus liquid;

[0026] 2. Take the infectious porcine transmissible gastroenteritis virus liquid in step 1 and add it to the sodium alginate liquid, and mix well; drop it into the mixed liquid of calcium chloride and chitosan acetic acid at a constant speed; Stir at a constant speed of 400r / min to make the film-fo...

specific Embodiment approach 2

[0027] Specific embodiment two: the difference between this embodiment and specific embodiment one is: infection of porcine gastroenteritis virus virus strain HLJ2017 strain. Others are the same as in the first embodiment.

specific Embodiment approach 3

[0028] Embodiment 3: This embodiment differs from Embodiment 1 in that subculturing the infected porcine gastroenteritis virus strain refers to continuously subculturing the HLJ2017 strain on ST cells. Others are the same as in the first embodiment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation method of an oral TGEV (transmissible gastroenteritis virus) deactivating microcapsule, and relates to a preparation method of an oral TGEV microcapsule, which aims at overcoming the technical defects of oral deactivating vaccine in the existing domestic preventing and controlling phase of TGEV. The preparation method of the oral TGEV microcapsule is based on the TGEV deactivating and oral microcapsule preparation techniques. Proofed by animal experiment results, the preparation method has the advantages that the titer detection result of serum neutralizingantibody indicates that the microcapsule vaccine can induce the response of mucosal immune and system immune of a piglet and produce higher level of serum and mucosal antibodies, and objectively indicates that the microcapsule vaccine has certain slow-release effect; after the antigen matter of the microcapsule vaccine is orally taken by the piglet, the expression of specific antibodies IgG and IgA of the piglet can be induced, the resistance ability of the piglet to TGEV is improved, the death rate of the piglet is reduced, and the antivirus protection rate is 60 to 75% higher than the antivirus protection rate of a control group.

Description

technical field [0001] The invention relates to the inactivation technology of porcine transmissible gastroenteritis virus and the preparation technology and method of microcapsules. Background technique [0002] Infection with porcine transmissible gastroenteritis virus (TGEV) is one of the main causes of porcine viral diarrhea (TGEV), which is characterized by severe enteritis, vomiting, watery diarrhea, and weight loss. The disease occurs throughout the year, especially in winter, and pigs of all ages are susceptible to infection, but it is the most harmful to piglets and has the highest case fatality rate. Severe piglet mortality makes TGEV infection a major factor in the loss of China's pig industry. The life cycle of a coronavirus begins by invading living cells. After the adsorption is completed, the virus needs to enter the cytoplasm of the host cell in the next step. The virus can insert into the cell membrane and fuse with the membrane of the helper cell, thereb...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K39/225A61K9/50A61K47/36A61P31/14
CPCA61K39/12A61K9/5036A61K2039/5252A61K2039/542A61K2039/552A61K2039/575C12N2770/20034
Inventor 姜新鹏高利刘娣
Owner 姜新鹏
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products